On December 13, 2023, Prelude Therapeutics Incorporated closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | -3.51% | -5.90% | -10.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.30% | 219M | |
+25.32% | 48.09B | |
+46.90% | 40.62B | |
-3.36% | 40.43B | |
-6.20% | 28.36B | |
+9.52% | 24.89B | |
-20.44% | 19.01B | |
+28.33% | 12.09B | |
+0.97% | 11.88B | |
-1.29% | 11.8B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Prelude Therapeutics Incorporated announced that it has received $24.999997 million in funding